Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Erlotinib | 0.1 | uM | 9 | 2500.00 | 1434.95 | 3428.00 | 3812.75 | 0.8991 | 0.8547 |
| BT-20 | Erlotinib | 0.1 | uM | 7 | 625.00 | 270.29 | 817.00 | 712.50 | 1.1467 | 1.2056 |
| MCF 10A | Erlotinib | 0.01 | uM | 7 | 156.25 | 15.92 | 183.00 | 133.50 | 1.3708 | 1.2165 |
| BT-20 | Erlotinib | 1 | uM | 9 | 1250.00 | 684.27 | 1495.00 | 1780.00 | 0.8399 | 0.7623 |
| BT-20 | Erlotinib | 19.9526 | uM | 9 | 1250.00 | 684.27 | 946.00 | 1780.00 | 0.5315 | 0.2647 |
| MCF 10A | Erlotinib | 0.0033113 | uM | 7 | 156.25 | 15.92 | 156.00 | 133.50 | 1.1685 | 1.1041 |
| MCF 10A | Erlotinib | 3.1623 | uM | 7 | 156.25 | 15.92 | 62.00 | 133.50 | 0.4644 | 0.5577 |
| BT-20 | Erlotinib | 0.1 | uM | 9 | 1250.00 | 684.27 | 1738.00 | 1780.00 | 0.9764 | 0.9657 |
| BT-20 | Erlotinib | 0.031623 | uM | 9 | 1250.00 | 684.27 | 2137.00 | 1780.00 | 1.2006 | 1.2834 |
| BT-20 | Erlotinib | 10 | uM | 9 | 1250.00 | 684.27 | 1104.00 | 1780.00 | 0.6202 | 0.4146 |
| BT-20 | Erlotinib | 19.9526 | uM | 9 | 2500.00 | 1434.95 | 1999.00 | 3812.75 | 0.5243 | 0.2651 |
| BT-20 | Erlotinib | 10 | uM | 7 | 312.50 | 133.67 | 235.00 | 277.50 | 0.8469 | 0.7081 |
| BT-20 | Erlotinib | 19.9526 | uM | 7 | 312.50 | 133.67 | 532.00 | 277.50 | 1.9171 | 2.7088 |
| BT-20 | Erlotinib | 0.31623 | uM | 9 | 625.00 | 320.09 | 979.00 | 817.25 | 1.1979 | 1.2857 |
| BT-20 | Erlotinib | 0.31623 | uM | 7 | 312.50 | 133.67 | 328.00 | 277.50 | 1.1820 | 1.3439 |
| BT-20 | Erlotinib | 0.0033113 | uM | 7 | 312.50 | 133.67 | 287.00 | 277.50 | 1.0342 | 1.0649 |
| BT-20 | Erlotinib | 0.01 | uM | 9 | 625.00 | 320.09 | 700.00 | 817.25 | 0.8565 | 0.7836 |
| BT-20 | Erlotinib | 3.1623 | uM | 9 | 625.00 | 320.09 | 592.00 | 817.25 | 0.7244 | 0.5757 |
| BT-20 | Erlotinib | 0.031623 | uM | 9 | 625.00 | 320.09 | 907.00 | 817.25 | 1.1098 | 1.1602 |
| BT-20 | Erlotinib | 10 | uM | 9 | 625.00 | 320.09 | 610.00 | 817.25 | 0.7464 | 0.6110 |
| BT-20 | Erlotinib | 0.1 | uM | 9 | 625.00 | 320.09 | 832.00 | 817.25 | 1.0180 | 1.0266 |
| BT-20 | Erlotinib | 0.0033113 | uM | 9 | 312.50 | 153.73 | 302.00 | 312.00 | 0.9680 | 0.9372 |
| BT-20 | Erlotinib | 19.9526 | uM | 9 | 625.00 | 320.09 | 843.00 | 817.25 | 1.0315 | 1.0464 |
| MCF 10A | Erlotinib | 1 | uM | 7 | 625.00 | 98.92 | 386.00 | 6599.25 | 0.0585 | 0.2519 |
| MCF 10A | Erlotinib | 0.31623 | uM | 7 | 156.25 | 15.92 | 142.00 | 133.50 | 1.0637 | 1.0406 |